revised
AMERICAN ACADEMY OF PEDIATRICS
Clinical Practice Guideline: Treatment of the School-Aged Child With Attention-Deficit/Hyperactivity Disorder
Subcommittee on Attention-Deficit/Hyperactivity Disorder Committee on Quality Improvement
Pediatrics October 2001, 108 (4) 1033-1044; DOI: https://doi.org/10.1542/peds.108.4.1033

Article Information
vol. 108 no. 4 1033-1044
PubMed
Published By
Print ISSN
Online ISSN
History
- Published online October 1, 2001.
Copyright & Usage
Copyright © 2001 American Academy of Pediatrics
Author Information
- Subcommittee on Attention-Deficit/Hyperactivity Disorder Committee on Quality Improvement
Article usage
Cited By...
In this issue
Log in
You will be redirected to aap.org to login or to create your account.
Clinical Practice Guideline: Treatment of the School-Aged Child With Attention-Deficit/Hyperactivity Disorder
Subcommittee on Attention-Deficit/Hyperactivity Disorder Committee on Quality Improvement
Pediatrics Oct 2001, 108 (4) 1033-1044; DOI: 10.1542/peds.108.4.1033
Jump to section
Related Articles
Cited By...
- Mental health issues and psychological factors in athletes: detection, management, effect on performance and prevention: American Medical Society for Sports Medicine Position Statement--Executive Summary
- ADHD Diagnosis and Treatment Guidelines: A Historical Perspective
- Ten-Year Trends In Treatment Services For Children With Attention Deficit Hyperactivity Disorder Enrolled In Medicaid
- Risk of Suicidal Events With Atomoxetine Compared to Stimulant Treatment: A Cohort Study
- Variability in ADHD Care in Community-Based Pediatrics
- Collaborative Care Outcomes for Pediatric Behavioral Health Problems: A Cluster Randomized Trial
- Screening for Behavioral Health Issues in Children Enrolled in Massachusetts Medicaid
- Effect of ADHD Treatment on Injury Rates
- Use of a Computerized Decision Aid for ADHD Diagnosis: A Randomized Controlled Trial
- Stimulant treatment and injury among children with attention deficit hyperactivity disorder: an application of the self-controlled case series study design
- Clinical Practice Pathways for Evaluation and Medication Choice for Attention-Deficit/Hyperactivity Disorder Symptoms in Autism Spectrum Disorders
- ADHD: Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents
- "PDSA-ADHD": A Newly Reported Syndrome
- Use of an Internet Portal to Improve Community-Based Pediatric ADHD Care: A Cluster Randomized Trial
- Computer-Assisted Management of Attention-Deficit/Hyperactivity Disorder
- Effect of Restricted Diet on ADHD Symptoms
- Patterns of Comorbidity, Functioning, and Service Use for US Children With ADHD, 2007
- The Nonmedical Use of Prescription Stimulants Among Dental and Dental Hygiene Students
- Contrasting Parents' and Pediatricians' Perspectives on Shared Decision-Making in ADHD
- Stimulant-Responsive and Stimulant-Refractory Aggressive Behavior Among Children With ADHD
- Electronic Health Record Decision Support and Quality of Care for Children With ADHD
- Shared Decision-Making in Pediatrics: A National Perspective
- Enhancing Pediatric Mental Health Care: Strategies for Preparing a Primary Care Practice
- Enhancing Pediatric Mental Health Care: Algorithms for Primary Care
- Modeled Economic Evaluation of Alternative Strategies to Reduce Sudden Cardiac Death Among Children Treated for Attention Deficit/Hyperactivity Disorder
- Lisdexamfetamine: A prodrug for the treatment of attention-deficit/hyperactivity disorder
- Taking the stress out of individualizing ADHD drug therapy
- Parental Angst Making and Revisiting Decisions About Treatment of Attention-Deficit/Hyperactivity Disorder
- The Future of Pediatrics: Mental Health Competencies for Pediatric Primary Care
- Attention-Deficit/Hyperactivity Disorder: How Much Responsibility Are Pediatricians Taking?
- Reexamining the Emperor's New Clothes: Ambiguities in Current Cardiac Screening Recommendations for Youth With Attention Deficit Hyperactivity Disorder
- Cardiovascular Risk Screening Before Starting Stimulant Medications and Prescribing Practices of Canadian Physicians: Impact of the Health Canada Advisory
- Cardiovascular Monitoring and Stimulant Drugs for Attention-Deficit/Hyperactivity Disorder
- Does Connection to Primary Care Matter for Children With Attention-Deficit/Hyperactivity Disorder?
- Community-wide Intervention to Improve the Attention-Deficit/Hyperactivity Disorder Assessment and Treatment Practices of Community Physicians
- Cardiovascular Monitoring of Children and Adolescents With Heart Disease Receiving Medications for Attention Deficit/Hyperactivity Disorder: A Scientific Statement From the American Heart Association Council on Cardiovascular Disease in the Young Congenital Cardiac Defects Committee and the Council on Cardiovascular Nursing
- Managing Attention-Deficit/Hyperactivity Disorder in Primary Care: A Systematic Analysis of Roles and Challenges
- Treating Attention-Deficit/Hyperactivity Disorder With a Stimulant Transdermal Patch: The Clinical Art
- Methylphenidate may improve symptoms but does not increase response compared with placebo in preschool children with ADHD
- The Global Market For ADHD Medications
- ADHD's toll: Research papers at AAP conference paint a picture of the disorder's debilitating social, educational and financial challenges
- National Estimates and Factors Associated With Medication Treatment for Childhood Attention-Deficit/Hyperactivity Disorder
- Stimulant-Drug Therapy for Attention-Deficit Disorder (With or Without Hyperactivity) and Sudden Cardiac Death
- Clinic assessment for methylphenidate maintenance therapy in secondary care: are parental questionnaires useful?
- Stimulants and Sudden Death: What Is a Physician to Do?
- THE ROLE OF THE POLYMORPHIC EFFLUX TRANSPORTER P-GLYCOPROTEIN ON THE BRAIN ACCUMULATION OF d-METHYLPHENIDATE AND d-AMPHETAMINE
- FDA panel recommends black box warning on ADHD stimulant medications
- Scope of Health Care Benefits for Children From Birth Through Age 21
- Acceptability of a Web-based Attention-deficit/Hyperactivity Disorder Scale (T-SKAMP) by Teachers: A Pilot Study
- Effect of methylphenidate formulation on treatment patterns and use of emergency room services
- Fragmented Care for Inner-City Minority Children With Attention-Deficit/Hyperactivity Disorder
- Attention-deficit hyperactivity disorder: should we believe the mass media or peer-reviewed literature?
- ASHP Therapeutic Position Statement on the Appropriate Use of Medications in the Treatment of Attention-Deficit/Hyperactivity Disorder in Pediatric Patients
- Effects of Atomoxetine on Growth After 2-Year Treatment Among Pediatric Patients With Attention-Deficit/Hyperactivity Disorder
- Attention-Deficit/Hyperactivity Disorder Among Adolescents: A Review of the Diagnosis, Treatment, and Clinical Implications
- Treatment of Attention-Deficit/Hyperactivity Disorder: Overview of the Evidence
- A Process for Developing Community Consensus Regarding the Diagnosis and Management of Attention-Deficit/Hyperactivity Disorder
- Short-Term Efficacy of Methylphenidate: A Randomized, Double-Blind, Placebo-Controlled Trial Among Survivors of Childhood Cancer
- Use of stimulants for attention deficit hyperactivity disorder: AGAINST
- Use of stimulants for attention deficit hyperactivity disorder: FOR
- Effects of a Primary Care-Based Intervention on Violent Behavior and Injury in Children
- Use of Practice Guidelines in the Primary Care of Children With Attention-Deficit/Hyperactivity Disorder
- A Comparison of Once-Daily Extended-Release Methylphenidate Formulations in Children With Attention-Deficit/Hyperactivity Disorder in the Laboratory School (The Comacs Study)
- 2001 American Academy of Pediatrics Practice Parameter on Attention-Deficit/Hyperactivity Disorder
- Measuring the Quality of Children's Health Care: A Prerequisite to Action
- Attention-Deficit/Hyperactivity Disorder in School-Aged Children: Association With Maternal Mental Health and Use of Health Care Resources
- Are psychostimulant drugs being used appropriately to treat child and adolescent disorders?
- Diagnosis and Treatment of ADHD in School-age Children in Primary Care Settings: A Synopsis of the AAP Practice Guidelines
- Geographic Variation in the Prevalence of Stimulant Medication Use Among Children 5 to 14 Years Old: Results From a Commercially Insured US Sample
- Getting your arms around ADHD: New tools help pediatricians implement Academy's recent diagnostic guidelines
- Managing Stimulant Medication for Attention-Deficit/Hyperactivity Disorder: An Update
- How to Diagnose and Treat ADHD: New AAP Guidelines
- Quality in Pediatrics: A Progress Report for the American Academy of Pediatrics
- Methylphenidate in the treatment of children with attention-deficit hyperactivity disorder
- ADHD: More Practice Guidelines
- The New Morbidity: Where the Rubber Hits the Road or the Practitioner's Guide to the New Morbidity
- ADHD: More Practice Guidelines
- Guideline: Treat ADHD as a chronic disease : AAP issues evidence-based recommendations